肌肉生长抑制素：慢性肾脏病中肌肉减少症与心血管疾病之间的缺失环节？ - Suppr

Suppr

超能文献

Myostatin: The Missing Link between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease?

作者信息

Morioka Tomoaki

机构信息

Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine.

出版信息

J Atheroscler Thromb. 2020 Oct 1;27(10):1036-1038. doi: 10.5551/jat.ED129. Epub 2020 May 20.

DOI:10.5551/jat.ED129

PMID:32435012

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7585907/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc2/7585907/9dc496e4774f/jat-27-1036-g001.jpg

相似文献

Myostatin: The Missing Link between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease?肌肉生长抑制素：慢性肾脏病中肌肉减少症与心血管疾病之间的缺失环节？

J Atheroscler Thromb. 2020 Oct 1;27(10):1036-1038. doi: 10.5551/jat.ED129. Epub 2020 May 20.

Myostatin and sarcopenia: opportunities and challenges - a mini-review.肌肉生长抑制素与肌肉减少症：机遇与挑战——一篇综述短文

Gerontology. 2014;60(4):289-93. doi: 10.1159/000356740. Epub 2014 Jan 17.

Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.骨骼并非孤立无援：慢性肾脏病中骨骼肌功能障碍的影响

Curr Osteoporos Rep. 2015 Jun;13(3):173-9. doi: 10.1007/s11914-015-0261-4.

The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.肌少症性肥胖中肌肉生长抑制素信号传导的恶性循环：肌肉生长抑制素在骨骼肌生长、胰岛素信号传导中的作用及对临床试验的影响

J Frailty Aging. 2018;7(1):21-27. doi: 10.14283/jfa.2017.33.

Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications.体育锻炼与肌肉因子：与肌肉减少症和心血管并发症的关系。

Int J Mol Sci. 2020 May 20;21(10):3607. doi: 10.3390/ijms21103607.

Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study.硫酸吲哚酚可能在肌肉减少症中起作用，而肌肉生长抑制素是慢性肾脏病患者肌肉量的指标：来自 RECOVERY 研究的分析。

Toxins (Basel). 2022 Sep 23;14(10):660. doi: 10.3390/toxins14100660.

TGF-β superfamily signaling in muscle and tendon adaptation to resistance exercise.肌肉和肌腱对阻力训练适应过程中的转化生长因子-β超家族信号传导

Exerc Sport Sci Rev. 2015 Apr;43(2):93-9. doi: 10.1249/JES.0000000000000041.

Molecular mechanism of sarcopenia and cachexia: recent research advances.肌肉减少症和恶病质的分子机制：最新研究进展

Pflugers Arch. 2017 Jun;469(5-6):573-591. doi: 10.1007/s00424-016-1933-3. Epub 2017 Jan 19.

Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.抗肌生成抑制素抗体可增加老年小鼠的肌肉质量和力量，并改善其胰岛素敏感性。

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2212-7. doi: 10.1073/pnas.1525795113. Epub 2016 Feb 8.

Healthy community-living older men differ from women in associations between myostatin levels and skeletal muscle mass.健康的社区生活老年男性与女性在肌肉生长抑制素水平和骨骼肌质量之间的关联存在差异。

J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):635-642. doi: 10.1002/jcsm.12302. Epub 2018 Apr 13.

引用本文的文献

Osteosarcopenia in Chronic Kidney Disease: An Overlooked Syndrome?慢性肾脏病中的骨少肌少症：一种被忽视的综合征？

J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13787. doi: 10.1002/jcsm.13787.

Muscle Wasting and Arteriovenous Fistula Nonmaturation in Kidney Failure.肾衰竭中的肌肉萎缩与动静脉内瘘未成熟

J Am Soc Nephrol. 2025 May 1;36(5):758-759. doi: 10.1681/ASN.0000000683. Epub 2025 Mar 26.

Association between Sarcopenia and Insulin-Like Growth Factor-1, Myostatin, and Insulin Resistance in Elderly Patients Undergoing Hemodialysis.老年血液透析患者肌肉减少症与胰岛素样生长因子-1、肌肉生长抑制素及胰岛素抵抗之间的关联

J Aging Res. 2022 Mar 23;2022:1327332. doi: 10.1155/2022/1327332. eCollection 2022.

The Correlation of Serum Myostatin Levels with Gait Speed in Kidney Transplantation Recipients.血清肌肉生长抑制素水平与肾移植受者步态速度的相关性。

Int J Environ Res Public Health. 2022 Jan 1;19(1):465. doi: 10.3390/ijerph19010465.

本文引用的文献

Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease.终末期肾病患者动脉壁中的肌肉抑制素。

J Atheroscler Thromb. 2020 Oct 1;27(10):1039-1052. doi: 10.5551/jat.51144. Epub 2020 Mar 14.

Serum myostatin levels are associated with abdominal aortic calcification in dialysis patients.血清肌生成抑制素水平与透析患者腹主动脉钙化有关。

Kidney Res Clin Pract. 2019 Dec 31;38(4):481-489. doi: 10.23876/j.krcp.19.019.

Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation.抑瘤素 M 通过调节肌肉分化和降解诱导 C2C12 肌管萎缩。

Biochem Biophys Res Commun. 2019 Aug 27;516(3):951-956. doi: 10.1016/j.bbrc.2019.06.143. Epub 2019 Jul 2.

Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.肌肉生长抑制素及其抑制物在慢性肾脏病中的新作用。

Kidney Int. 2019 Mar;95(3):506-517. doi: 10.1016/j.kint.2018.10.010. Epub 2018 Dec 28.

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.日本动脉粥样硬化协会（JAS）2017年动脉粥样硬化性心血管疾病预防指南。

J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.

Crossing Bridges between Extra- and Intra-Cellular Events in Thoracic Aortic Aneurysms.胸主动脉瘤中外细胞事件的桥梁交汇。

J Atheroscler Thromb. 2018 Feb 1;25(2):99-110. doi: 10.5551/jat.RV17015. Epub 2017 Sep 22.

Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment.肌肉生长抑制素通过诱导血管平滑肌细胞功能障碍和单核细胞募集来介导腹主动脉粥样硬化进展。

Sci Rep. 2017 Apr 13;7:46362. doi: 10.1038/srep46362.

The heart and vascular system in dialysis.透析中的心脏和血管系统。

Lancet. 2016 Jul 16;388(10041):276-84. doi: 10.1016/S0140-6736(16)30508-6. Epub 2016 May 22.

Therapeutics targeting persistent inflammation in chronic kidney disease.针对慢性肾脏病持续性炎症的治疗方法。

Transl Res. 2016 Jan;167(1):204-13. doi: 10.1016/j.trsl.2015.06.012. Epub 2015 Jun 25.

Mechanisms of muscle wasting in chronic kidney disease.慢性肾脏病中肌肉减少症的发生机制。

Nat Rev Nephrol. 2014 Sep;10(9):504-16. doi: 10.1038/nrneph.2014.112. Epub 2014 Jul 1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验